Χώρα: Ταϊβάν
Γλώσσα: Κινεζικά
Πηγή: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
DESOGESTREL;;ESTRADIOL ETHINYL (EQ TO ETHINYLOESTRADIOL)(EQ TO ETHINYLESTRADIOL)
美商默沙東藥廠股份有限公司台灣分公司 台北市信義區信義路五段106號12樓 (86683720)
G03AA09
錠劑
ESTRADIOL ETHINYL (EQ TO ETHINYLOESTRADIOL)(EQ TO ETHINYLESTRADIOL) (6816000600) MG; DESOGESTREL (6832001400) MG
盒裝
製 劑
須由醫師處方使用
N.V. ORGANON KLOOSTERSTRAAT 6 5349 AB OSS,THE NETHERLANDS NL
desogestrel and ethinylestradiol
口服避孕劑
註銷日期: 2019/01/18; 註銷理由: 自請註銷; 有效日期: 2018/05/21; 英文品名: MARVELON TABLETS
已註銷
1987-09-16
1. Marvelon tablets 2. 0.150desogestrel 0.030ethinylestradiol 80 6.1 3. 6 Organon* 4. 4.1 4.2 4.2.1 MARVELON 21 7 4.2.2 MARVELON • ( ) ( ) • ( ) Marvelon Marvelon • ( IUS ) • • 4.6 21~28 Marvelon (venous thromboembolism, VTE) ( 4.4) 4.2.3 12 12 1. 7 2. 7── 7 7 7 7 7 7 1. TR 5 4.3 (combined hormonal contraceptives; CHCs) CHCs (venous thromboembolism VTE) VTE 1. (deep vein thrombosis DVT) (pulmonary embolismPE) 2. C (APC) III (antithrombin III deficiency)CS) 3. ( 4.4 ) 4. (arterial thromboembolism ATE) ATE 1. 2. (stroke) (transient ischemic attack TIA) 3. (hyperhomocysteinaemia) (antiphospholipid antibodies) 4. (4.4.1) 5. (4.4.1) (1) (2) (3) (dyslipoproteinaemia) () ( ) Marvelon Marvelon C (HCV) ombitasvir/ paritaprevir/ritonavir / dasabuvir ( 4.4 ) 4.4 4.4.1 / CHCs CHCs CHCs (combined oral contraceptives; COCs) CHCs CHCs l e v o n o r g e s t r e l n o r g e s t i m a t e norethisterone ( ) COCs levonorgestrel COCs (VTE) 2 1 2 (VTE) 2 CHCs CHCs (VTE) CHCs(VTE) 10,000 (women-years; WY)1 5 10,000 CHCs 1 5 (VTE) CHCs(VTE) 10,000 3 12 ( 10,000 5 20 ) (VTE)1-2% S-CCDS-MK8276A-MRV21-TB-082016 8276A-TWN-2016-014180 016025 2. 7 4.2.4 3 4 4.2.3 4.2.5 7 () NON-CHC* USER, NON-PREGNANT CHC-USER PREGNANCY** POSTPARTUM (12 WEEKS ONLY) RANGES FROM 1 TO 5 RANGES FROM 3 TO 12 RANGES FROM 5 TO 20 NUMBER OF WOMEN WITH A BLOOD CLOT OUT OF 10,000 WOMAN-YEARS (WY) RANGES FROM 40 TO 65 0 10 20 30 40 50 60 70 *CHC= ** 9 (women-years; WY) 727 (VENOUS THROMBOEMBOLISM VTE) CHCs VTE VTE CHCs 4 CHCs CHCs ( ) VTE CHCs VTE VTE Marvelon CHCs CHCs (BMI >30 kg/m 2 ) ( 50 ) BMI CHCs ( ) ( 4.3 ) Marvelon ( ) (sickle cell disease) 35 35 CHCs 35 VTE ( ) (4.6) VTE () CHCs (1) ‒ (/) ‒ ‒ (2) ‒ ‒ ‒ ‒ ‒ ( ) () (ARTERIAL THROMBOEMBOLISMATE) CHCs ( ) ( ) ATE CHCs ATE Marvelon CHCs CHCs 1. [] ( ) ( ) (IUS) C (APC) antithrombin-III C S () / ATE CHCs (1) ‒ () ‒ ‒ ‒ ‒ ‒ ‒ (2) ‒ ‒ ‒ ‒ ‒ ‒ (HPV) COCs 54 meta-analysis COCs(RR = 1.24) COC COC COCs COCs COC COCs COCs C ombitasvir/paritaprevir/ ritonavir ( / dasa Διαβάστε το πλήρες έγγραφο